Edmond de Rothschild Holding’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5M | Buy |
49,869
+37,263
| +296% | +$8.02M | 0.17% | 121 |
|
|
2026
Q1 | $2.74M | Sell |
12,606
-2,178
| -15% | -$483K | 0.04% | 208 |
|
|
2025
Q4 | $3.38M | Sell |
14,784
-15,872
| -52% | -$3.62M | 0.05% | 198 |
|
|
2025
Q3 | $7.1M | Buy |
30,656
+1,911
| +7% | +$389K | 0.11% | 149 |
|
|
2025
Q2 | $5.34M | Sell |
28,745
-2,326
| -7% | -$432K | 0.09% | 169 |
|
|
2025
Q1 | $6.51M | Buy |
31,071
+4,409
| +17% | +$857K | 0.11% | 146 |
|
|
2024
Q4 | $4.74M | Buy |
26,662
+167
| +0.6% | +$30.7K | 0.08% | 173 |
|
|
2024
Q3 | $5.23M | Buy |
26,495
+9,525
| +56% | +$1.78M | 0.08% | 168 |
|
|
2024
Q2 | $2.91M | Sell |
16,970
-3,140
| -16% | -$520K | 0.05% | 192 |
|
|
2024
Q1 | $3.66M | Sell |
20,110
-4,685
| -19% | -$807K | 0.06% | 180 |
|
|
2023
Q4 | $3.84M | Sell |
24,795
-3,088
| -11% | -$450K | 0.07% | 177 |
|
|
2023
Q3 | $4.16M | Buy |
27,883
+1,808
| +7% | +$265K | 0.08% | 169 |
|
|
2023
Q2 | $3.51M | Buy |
26,075
+11,424
| +78% | +$1.68M | 0.07% | 200 |
|
|
2023
Q1 | $2.33M | Sell |
14,651
-14,988
| -51% | -$2.29M | 0.05% | 232 |
|
|
2022
Q4 | $4.79M | Buy |
29,639
+2,482
| +9% | +$381K | 0.11% | 163 |
|
|
2022
Q3 | $3.64M | Buy |
27,157
+619
| +2% | +$88.8K | 0.1% | 181 |
|
|
2022
Q2 | $4.06M | Buy |
26,538
+4,300
| +19% | +$657K | 0.1% | 176 |
|
|
2022
Q1 | $3.6M | Buy |
22,238
+9,474
| +74% | +$1.38M | 0.08% | 192 |
|
|
2021
Q4 | $1.73M | Buy |
12,764
+4,367
| +52% | +$516K | 0.04% | 315 |
|
|
2021
Q3 | $906K | Buy |
8,397
+1,421
| +20% | +$162K | 0.02% | 381 |
|
|
2021
Q2 | $786K | Buy |
6,976
+95
| +1% | +$10.7K | 0.02% | 389 |
|
|
2021
Q1 | $744K | Buy |
6,881
+2,340
| +52% | +$250K | 0.02% | 353 |
|
|
2020
Q4 | $486K | Sell |
4,541
-866
| -16% | -$83.2K | 0.02% | 355 |
|
|
2020
Q3 | $473K | Hold |
5,407
| – | – | 0.02% | 319 |
|
|
2020
Q2 | $530K | Sell |
5,407
-2,157
| -29% | -$190K | 0.02% | 283 |
|
|
2020
Q1 | $576K | Hold |
7,564
| – | – | 0.03% | 255 |
|
|
2019
Q4 | $670K | Sell |
7,564
-2,000
| -21% | -$166K | 0.03% | 272 |
|
|
2019
Q3 | $722K | Hold |
9,564
| – | – | 0.03% | 276 |
|
|
2019
Q2 | $695K | Buy |
9,564
+7,564
| +378% | +$595K | 0.03% | 266 |
|
|
2019
Q1 | $161K | Sell |
2,000
-4,405
| -69% | -$360K | 0.01% | 387 |
|
|
2018
Q4 | $590K | Sell |
6,405
-385
| -6% | -$33.9K | 0.02% | 295 |
|
|
2018
Q3 | $642K | Buy |
6,790
+1,422
| +26% | +$135K | 0.02% | 315 |
|
|
2018
Q2 | $497K | Hold |
5,368
| – | – | 0.01% | 340 |
|
|
2018
Q1 | $507K | Sell |
5,368
-750
| -12% | -$82.4K | 0.01% | 349 |
|
|
2017
Q4 | $591K | Sell |
6,118
-200
| -3% | -$18.8K | 0.02% | 335 |
|
|
2017
Q3 | $561K | Sell |
6,318
-700
| -10% | -$53.3K | 0.02% | 351 |
|
|
2017
Q2 | $509K | Sell |
7,018
-1,006
| -13% | -$67.6K | 0.01% | 377 |
|
|
2017
Q1 | $523K | Sell |
8,024
-2,394
| -23% | -$151K | 0.01% | 369 |
|
|
2016
Q4 | $652K | Buy |
10,418
+4,007
| +63% | +$245K | 0.02% | 334 |
|
|
2016
Q3 | $404K | Hold |
6,411
| – | – | 0.01% | 419 |
|
|
2016
Q2 | $397K | Sell |
6,411
-1,456
| -19% | -$88.7K | 0.01% | 411 |
|
|
2016
Q1 | $449K | Sell |
7,867
-300
| -4% | -$16.7K | 0.01% | 379 |
|
|
2015
Q4 | $484K | Sell |
8,167
-350
| -4% | -$20.2K | 0.01% | 366 |
|
|
2015
Q3 | $463K | Buy |
8,517
+1,100
| +15% | +$71.6K | 0.01% | 357 |
|
|
2015
Q2 | $498K | Buy |
+7,417
| New | +$484K | 0.01% | 378 |
|
Other funds holding ABBV
Edmond de Rothschild Holding's ABBV Position: Q2 2026 in Review
Edmond de Rothschild Holding increased its AbbVie (ABBV) stake by 296% in Q2 2026, buying an estimated $8.02M and bringing the position to 49,869 shares worth $12.5M. The position accounts for 0.17% of the portfolio, ranked #121.
Edmond de Rothschild Holding first reported a position in ABBV in Q2 2015 and has held it in 45 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Edmond de Rothschild Holding held 49,869 shares of AbbVie worth $12.5M as of Q2 2026.
- Edmond de Rothschild Holding bought 37,263 AbbVie shares in Q2 2026, an estimated $8.02M.
- AbbVie made up 0.17% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #121 holding.
- Edmond de Rothschild Holding first reported a position in AbbVie in Q2 2015 and has held it in 45 quarters since.
- 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.